CD-ROM

Switch studies

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDB094 Abstract Raltegravir is effective in HIV-1 group O infected patients A. Depatureaux1,2, M. Leoz1, G. Le Moal3, J.-P. Pathé4, J. Pavie5, F. Simon5, J.-C. Plantier1,2 1CHU Charles Nicolle, Rouen, France, 2Université de Rouen, Rouen, France, 3CHU La Milétrie, Poitiers, France, 4CHI Eure Seine, Evreux, France, 5CHU Saint Louis, Paris, France CDB124 Abstract HIV treatment attrition among young adults: case studies from a rural ugandan trading centre- a qualitative study S. Carter1, P. Spittal1, N. Sewankambo2, D. Willms3, K. Mugabo4, B. Magambo5, H. Birungi6 1University of British Columbia, School of Population and Public Health, Vancouver, Canada, 2Makerere University, Medicine, Kampala, Uganda, 3McMaster University, Anthropology, Hamilton, Canada, 4Kampala Martyr's University, Development Studies, Kampala, Uganda, 5Makerere University, Social Sciences, Kampala, Uganda, 6Makerere University, Communications, Kampala, Uganda CDB125 Abstract Differences among antiretroviral regimen classes and antiretroviral adherence toward achieving viral control below limits of quantification ("BLQ") M. Horberg1, L. Hurley2, W. Towner3, R. Gambatese4, D. Klein5, D. Antoniskis6, W. Weinberg7, C. Quesenberry2, M. Johnson4, M. Silverberg2 1Kaiser Permanente, HIV Initiative, Oakland, United States, 2Kaiser Permanente Northern California Division of Research, Oakland, United States, 3Kaiser Permanente Southern California, HIV Medicine, Los Angeles, United States, 4Kaiser Permanente, Oakland, United States, 5Kaiser Permanente Northern California, Infectious Diseases and HIV, Hayward, United States, 6Kaiser Permanente Northwest, Infectious Diseases and HIV, Portland, United States, 7Kaiser Permanente Georgia, Infectious Diseases and HIV, Atlanta, United States CDB126 Abstract Estimate of the observance of the antiretroviral treatment at the persons living with the HIV/AIDS in Burundi B. Nkurunziza1, E. Nindagiye2, G. Nsengiyumva3, E. Baramperanye4, C. Nyamuzangura5, F. Musanabana6, E.G. Barutwanayo7, E. Nimbona8, T. Niyongabo9, D. Mbonihankuye10 1Centre Nationale de Reference en Matière de VIH/SIDA, Recherche, Bujumbura, Burundi, 2Centre Nationale de Reference en Matière de VIH/SIDA, Statistique, Bujumbura, Burundi, 3Central Asia AIDS Control Project, Recherche, Bujumbura, Burundi, 4ANSS, Prise en Charge Médicale des PVVIH, Bujumbura, Burundi, 5CPAMP CHUK, Prise en Charge Médicale des PVVIH, Bujumbura, Burundi, 6CPAMP HPRC, Prise en Charge Médicale des PVVIH, Bujumbura, Burundi, 7Nouvelle Espérance, Prise en Charge Médicale des PVVIH, Bujumbura, Burundi, 8ANSS Kirundo, Prise en Charge Médicale des PVVIH, Bujumbura, Burundi, 9Centrale Nationale de reference, Bujumbura, Burundi, 10Secretariat Executif Permenent du SEP CNLS, Bujumbura, Burundi CDB127 Abstract Food insecurity as a barrier to antiretroviral therapy (ART) adherence among HIV-infected individuals S.D. Weiser1, K. Fernandes2, A. Anema2, E. Brandson2, V. Lima2, J. Montaner2,3, R. Hogg2,4 1University of California San Francisco, Positive Health Program and Center for AIDS Prevention Studies, San Francisco, United States, 2BC Centre for Excellence in HIV/ AIDS, Vancouver, Canada, 3University of British Columbia, Vancouver, Canada, 4Simon Fraser University, Vancouver, Canada CDB128 Abstract Diverse patterns of non-adherence are associated with differently impaired genotypic resistance test at HAART virological failure A. Ammassari1, M.P. Trotta1, P. Marconi1, M. Zaccarelli1, P. Sette1, P. Pierro1, F. Forbici1, C.F. Perno2, A. Antinori1 1INMI L Spallanzani, Clinical Department, Rome, Italy, 2Tor Vergata University, Rome, Italy